Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Retrophin provides access to RE-024 in pantothenate kinase-associated neurodegeneration

May 16, 2014

Ligand signs agreement with Omthera Pharmaceuticals for dyslipidemia-related diseases

May 16, 2014

Alexion studies ALXN-1007 for non-criteria manifestations of antiphospholipid syndrome

May 15, 2014

Catabasis Pharmaceuticals presents preclinical data for CAT-2003

May 15, 2014

Xenetic Biosciences reports phase I results for oxyntomodulin analogue

May 14, 2014

AstraZeneca announces phase III results for saxagliptin/dapagliflozin combination

May 13, 2014

Lilly reports positive phase III results for insulin peglispro

May 13, 2014

Abeona Therapeutics' therapies obtain orphan drug designation for Sanfilippo syndrome

May 13, 2014

Evotec and Eternygen to identify and develop novel metabolic disease therapy

May 9, 2014

reMYND's novel diabetes treatment prevents disease progression in mouse model

May 9, 2014

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...